Scan barcode

1268 pages • missing pub info (editions)
ISBN/UID: 9781482298918
Format: Hardcover
Language: English
Publisher: CRC Press
Publication date: 23 December 2015
Description
What's the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for la...
Community Reviews
Content Warnings

1268 pages • missing pub info (editions)
ISBN/UID: 9781482298918
Format: Hardcover
Language: English
Publisher: CRC Press
Publication date: 23 December 2015
Description
What's the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for la...